- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02925286
Effects of a Workplace Prevention Program for Problematic Gambling (Alna)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is a considerable knowledge-gap regarding the efficacy of problem gambling prevention in workplace settings. At the same time, this knowledge is widely requested upon both by researchers and government agencies. The evaluation of prevention programs is important both in a public health perspective and for the organizations investing in preventive interventions for problem gambling at the workspaces and the current study aims to contribute with knowledge regarding the potential effects of such an intervention.
The purpose of this study is to determine the effects of a workplace prevention program regarding problematic gambling, on a variety of outcomes. The authors hypothesize that the program will lead to differences in:
- A change in gambling habits among coworkers and managers
- That fewer workers and managers will report problem gambling
- That the managers who participate in the intervention will report being more confident in handling gambling and problem gambling at the workplace
- That the managers who participate in the intervention will report a higher inclination to engage in a conversation with an employee when suspicion or worry about problem gambling arises
- That the number of actions to help employees with problem gambling or other types of harmful use will raise among organizations who participate in the intervention.
- An increase in the employees' knowledge about what kind of support regarding gambling or addiction is available from the workplace and where to find it.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Program Inclusion Criteria:
- To be eligible to participate in the workplace program, the participant must be currently employed as manager in one of the organizations that will participate in the study
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Five organizations will get the intervention during fall/winter 2016.
|
The intervention group will receive a gambling prevention program which includes generating and implementing policies and education on addiction and gambling.
The full length of the program will be about 14 hours.
|
No Intervention: Wait-list group
Five organizations will be on the waitlist for 12 months and then get the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Survey question about supervisors perceived inclination to initiate a conversation with an employee when worry or suspicion of problematic gambling or other harmful use arises.
Time Frame: Change from baseline at: [1] 3 months after baseline, [2] 12 months after baseline, and [3] 24 months past baseline.
|
Change from baseline at: [1] 3 months after baseline, [2] 12 months after baseline, and [3] 24 months past baseline.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Survey questions about supervisors and workers gambling frequencies
Time Frame: [1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
Gambling frequencies online/offline in the last 1 and 12 month(s).
|
[1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
Survey questions about knowledge of present policies and where to go for help
Time Frame: [1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
[1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
|
Survey questions regarding worrying about, or acting to help, co-workers
Time Frame: [1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
[1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
|
Survey question regarding knowledge about whether co-workers gamble during work
Time Frame: [1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
[1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
|
The Problem Gambling Severity Index (PGSI)
Time Frame: [1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
[1] 3 months after baseline (Supervisors only) , [2] 12 months after baseline, and [3] 24 months past baseline.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Per Carlbring, Professor, Stockholm University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Alna
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gambling
-
Université Catholique de LouvainCentre Hospitalier Universitaire Vaudois; Cliniques universitaires Saint-Luc-... and other collaboratorsUnknownCraving | Gambling | Gambling Disorder | Gambling, Pathological | Gambling ProblemSwitzerland
-
ITAB - Institute for Advanced Biomedical TechnologiesNot yet recruitingAccelerated rTMS in Gambling Disorder: a Multicentric, Randomized, Sham-controlled Trial (arTMSinGD)Gambling | Gambling Disorder | Gambling, Pathological | Gambling Problem
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedGambling | Pathological Gambling | Problem GamblingUnited States
-
Region SkaneLund UniversityRecruitingGambling Disorder | Problem GamblingSweden
-
Universitat Jaume INot yet recruitingGambling Disorder | Problem GamblingSpain
-
University of ChicagoCompleted
-
Karolinska InstitutetCompleted
-
Finnish Institute for Health and WelfareUnknownNaloxone | Gambling Disorder | Opioid Antagonist | Pathological GamblingFinland
-
Lund UniversityAB Svenska SpelRecruitingGambling Disorder | Problem GamblingSweden
-
Karolinska InstitutetThe National Gambling Helpline SwedenNot yet recruiting
Clinical Trials on Prevention program for gambling in the workplace
-
Chulalongkorn UniversityNot yet recruitingChronic Disease | Noncommunicable Diseases
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedEnvironmental ExposureTaiwan
-
Ankara Yildirim Beyazıt UniversityCompletedOsteoporosis | Healthy Lifestyle | University StudentsTurkey
-
University of Colorado, DenverUnited States Department of Agriculture (USDA)Completed
-
Hospices Civils de LyonUnknownFalls Among Elderly InpatientsFrance
-
Nova Scotia Health AuthorityIWK Health CentreUnknownBurnout, Professional | Adaptation, PsychologicalCanada
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)Active, not recruitingHypertension | Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Overweight | PreDiabetes | Overweight and Obesity | Overweight or Obesity | High Blood Pressure | High Blood SugarUnited States
-
Emelie MalstamUniversity of GavleCompletedStroke | Cardiovascular Risk Factor | Non-Communicable DiseasesSweden
-
Nantes University HospitalUnknown
-
University Hospital, ToulouseInstitut National de la Santé Et de la Recherche Médicale, France; National... and other collaboratorsCompleted